返回 Agenda
Session 4: Pharmacovigilance
Session Chair(s)
Magnus Ekelo
Pharmacovigilance Officer
Uppsala Monitoring Centre, World Health Organisation, Sweden
Topics to be addressed and discussed: The implications, differences in terms of implementation in the region; what are the benefits from this legislation – Health Authority perspective; opinion sharing on harmonisation; reflection on and benefits of the new Pharmacovigilance legislation – Health Authority perspective; pharmacovigilance Rest of World group – overlap between systems and data
Speaker(s)
Common Arab Guidance – Updates
Amr Saad
Founder, The Egyptian Pharmacovigilance Center (EPVC) , Egypt
Former Associate Minister of Health for Pharmaceutical Affairs
Regional Implementation – Trends and Challenges for Future
Reem K Al Essa, MBA
Ministry of Health, Kuwait
Coordination & Development Superintendent Pharmaceutical Services Administration
Pharmacovigilance
Esteban Herrero-Martinez, PHD
Novartis Pharmaceuticals UK Limited, United Kingdom
Director Regulatory Policy and Intelligence